title: [Fresolimumab: A new treatment option for systemic scleroderma on the horizon?].
authors.affiliation: Hautklinik, Universitätsklinikum Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland. Bernhard.Homey@med.uni-duesseldorf.de.
authors.forename: B
authors.initials: B
authors.lastname: Homey
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D019317:Evidence-Based Medicine; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; C560928:fresolimumab